Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Gene-activated tri-layer 3D-bioprinted scaffold for enhanced osteochondral defect repair

Project description

Gene-activated implants for damaged joints

Damage to cartilage and the underlying bone can cause chronic pain, joint instability and eventually osteoarthritis. However, existing treatments rarely restore the tissue completely. With the support of the Marie Skłodowska-Curie Actions programme, the GATSO-3D project will develop a 3D-printed implant that closely mimics the structure of a healthy joint. The implant will contain three layers that deliver different therapeutic genes designed to promote cartilage and bone regeneration and reduce inflammation. By combining advanced biomaterials, nanotechnology and gene therapy, the implant is aimed at stimulating more effective and long-lasting tissue repair. This innovative approach could improve recovery after joint injuries, reduce the risk of osteoarthritis and enhance quality of life for millions of patients.

Objective

Osteochondral defects (OCDs) arise from trauma, inflammation, or degenerative disease, causing pain, joint instability, and, in severe cases, osteoarthritis (OA). Current treatments are limited by the tissue’s hierarchical structure, poor cartilage repair capacity, and inflammation-driven degeneration, underscoring the need for advanced therapeutic approaches. The primary goal of this project is to construct a tri-layer 3D-bioprinted scaffold with structural, mechanical, and functional gradients that mimic native cartilage, calcified cartilage, and subchondral bone. The scaffold will enable spatial delivery of nanoparticles carrying osteogenic, chondrogenic, and anti-inflammatory plasmid DNA encodings (e.g. SOX9, BMP-2) from distinct layers, allowing evaluation of spatially programmed gene delivery in enhancing OCD repair. Prof. Fergal O’Brien’s group at the Royal College of Surgeons in Ireland has expertise in natural polymer-based scaffolds for nucleic acid delivery. I will combine my experience in advanced polymer synthesis and 3D-printed scaffold fabrication with their nanomedicine technology to develop gene-activated nanoparticle-integrated tri-layered 3D-printed scaffold, creating a localized gene delivery platform to enhance therapeutic efficacy and ultimately alleviate patient suffering. I will be supervised by Prof. O’Brien, and he will guide my Career Development Plan. I will develop complementary skills in project management, leadership, entrepreneurship, commercialization, dissemination, and profile enhancement. Acquiring advanced research competencies and complementary skills, I will mature as an independent scientist, enhancing my professional visibility, capacity, and competitiveness in the field of biomaterials and tissue engineering. This Fellowship will significantly contribute to the achievement of my long-term career goal, which is to become an independent scientist leading my own research group focused on novel scaffolds for tissue engineering.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

ROYAL COLLEGE OF SURGEONS IN IRELAND
Net EU contribution
€ 252 728,64
Address
ST STEPHEN GREER 123
D02 YN77 DUBLIN 2
Ireland
Region
Ireland Eastern and Midland Dublin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data